Atta Behfar

8.8k total citations · 2 hit papers
179 papers, 6.2k citations indexed

About

Atta Behfar is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Atta Behfar has authored 179 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Surgery, 65 papers in Molecular Biology and 41 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Atta Behfar's work include Tissue Engineering and Regenerative Medicine (46 papers), Mechanical Circulatory Support Devices (31 papers) and Cardiac Structural Anomalies and Repair (29 papers). Atta Behfar is often cited by papers focused on Tissue Engineering and Regenerative Medicine (46 papers), Mechanical Circulatory Support Devices (31 papers) and Cardiac Structural Anomalies and Repair (29 papers). Atta Behfar collaborates with scholars based in United States, Belgium and China. Atta Behfar's co-authors include André Terzic, Carmen Pérez-Terzic, Ruben Crespo‐Diaz, Randolph S. Faustino, Michel Pucéat, Garvan C. Kane, Denice M. Hodgson, Satsuki Yamada, Leonid V. Zingman and Petras P. Dzeja and has published in prestigious journals such as Circulation, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Atta Behfar

165 papers receiving 6.0k citations

Hit Papers

Cardiopoietic Stem Cell Therapy in Heart Failure 2013 2026 2017 2021 2013 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atta Behfar United States 45 3.2k 2.8k 1.2k 1.0k 1.0k 179 6.2k
Young‐sup Yoon United States 41 3.6k 1.1× 2.4k 0.8× 1.8k 1.4× 635 0.6× 1.0k 1.0× 95 6.4k
Massimiliano Gnecchi Italy 31 3.2k 1.0× 3.0k 1.1× 2.8k 2.3× 1.2k 1.1× 1.4k 1.4× 99 6.7k
Eckhard Alt United States 46 2.2k 0.7× 3.5k 1.2× 2.3k 1.9× 3.0k 2.8× 945 0.9× 173 8.9k
Antonio Paolo Beltrami Italy 37 5.2k 1.6× 4.2k 1.5× 2.6k 2.1× 1.7k 1.6× 1.5k 1.5× 134 9.5k
Chuen Neng Lee Singapore 29 3.8k 1.2× 1.5k 0.5× 1.4k 1.2× 636 0.6× 585 0.6× 126 6.0k
Christof Stamm Germany 39 1.6k 0.5× 3.2k 1.1× 1.6k 1.3× 1.7k 1.6× 1.2k 1.2× 151 5.8k
Theo Kofidis Singapore 34 1.8k 0.6× 3.2k 1.1× 1.2k 1.0× 1.1k 1.0× 1.5k 1.5× 175 5.1k
Hyun‐Jai Cho South Korea 38 1.9k 0.6× 1.6k 0.5× 1.1k 0.9× 1.7k 1.6× 464 0.5× 166 5.0k
Qizhou Lian China 42 4.5k 1.4× 2.1k 0.8× 3.2k 2.7× 313 0.3× 511 0.5× 123 8.0k
Sonja Schrepfer United States 30 2.0k 0.6× 1.7k 0.6× 1.2k 1.0× 495 0.5× 431 0.4× 143 4.5k

Countries citing papers authored by Atta Behfar

Since Specialization
Citations

This map shows the geographic impact of Atta Behfar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atta Behfar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atta Behfar more than expected).

Fields of papers citing papers by Atta Behfar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atta Behfar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atta Behfar. The network helps show where Atta Behfar may publish in the future.

Co-authorship network of co-authors of Atta Behfar

This figure shows the co-authorship network connecting the top 25 collaborators of Atta Behfar. A scholar is included among the top collaborators of Atta Behfar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atta Behfar. Atta Behfar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Behfar, Atta, et al.. (2026). Purified Exosome Product Enhances Tendon-Bone Healing in a Rat Rotator Cuff Repair Model. The American Journal of Sports Medicine. 54(1). 162–173.
2.
Crespo‐Diaz, Ruben, Andrew Rosenbaum, Manish J. Gandhi, et al.. (2025). Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation. The Journal of Heart and Lung Transplantation. 44(8). 1300–1306. 1 indexed citations
3.
4.
Wang, Jie, Michèle Learmonth, Christopher J. Paradise, et al.. (2025). Extracellular Vesicles as a Promising Strategy for Aging Diabetic Kidney Disease. Cytotherapy. 27(5). S92–S92.
5.
Abbas, M., Rabea Asleh, Sudhir S. Kushwaha, et al.. (2024). Incidence and Risk Factors for Rejection After Conversion to Sirolimus-Based Immunosuppression in Orthotopic Heart Transplant Recipients. The Journal of Heart and Lung Transplantation. 43(4). S104–S104.
6.
Behfar, Atta, et al.. (2024). Evolving Role of Exosomes in Plastic and Reconstructive Surgery and Dermatology. Plastic & Reconstructive Surgery Global Open. 12(8). e6061–e6061. 3 indexed citations
7.
Arrell, D. Kent, Satsuki Yamada, Ryoung‐Hoon Jeon, et al.. (2024). Decoded cardiopoietic cell secretome linkage to heart repair biosignature. Stem Cells Translational Medicine. 13(11). 1144–1159. 3 indexed citations
8.
Livia, Christopher, Ruben Crespo‐Diaz, Matthew L. Hillestad, et al.. (2024). Infliximab Limits Injury in Myocardial Infarction. Journal of the American Heart Association. 13(9). e032172–e032172. 7 indexed citations
9.
Singh, Mandeep, Abdallah El Sabbagh, Bradley R. Lewis, et al.. (2023). Clinical Significance of Biological Age in Patients Undergoing Percutaneous Coronary Intervention. Mayo Clinic Proceedings. 98(8). 1137–1152. 3 indexed citations
10.
Al‐Hijji, Mohammed, Amrit Kanwar, Daniel J. Crusan, et al.. (2023). Risks of Right Heart Catheterization and Right Ventricular Biopsy. Mayo Clinic Proceedings. 98(3). 419–431. 6 indexed citations
12.
Yamada, Satsuki, Jozef Bartúnek, Thomas J. Povsic, et al.. (2023). Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial. Stem Cells Translational Medicine. 13(2). 116–124. 4 indexed citations
13.
Peterson, Timothy E., Raman Deep Singh, Ao Shi, et al.. (2022). Exosome biopotentiated hydrogel restores damaged skeletal muscle in a porcine model of stress urinary incontinence. npj Regenerative Medicine. 7(1). 58–58. 25 indexed citations
14.
Smith, Cambray, Megan Munsie, Atta Behfar, et al.. (2021). Academic Physician Specialists’ Approaches to Counseling Patients Interested in Unproven Stem Cell and Regenerative Therapies—A Qualitative Analysis. Mayo Clinic Proceedings. 96(12). 3086–3096. 5 indexed citations
15.
Arrell, D. Kent, Ruben Crespo‐Diaz, Satsuki Yamada, et al.. (2021). Secretome Signature of Cardiopoietic Cells Echoed in Rescued infarcted Heart Proteome. Stem Cells Translational Medicine. 10(9). 1320–1328. 7 indexed citations
16.
Yamada, Satsuki, et al.. (2021). Screening for Regenerative Therapy Responders in Heart Failure. Biomarkers in Medicine. 15(10). 775–783. 9 indexed citations
17.
Zyl, Martin van, Dawn Pedrotty, Erdem Karabulut, et al.. (2020). Injectable conductive hydrogel restores conduction through ablated myocardium. Journal of Cardiovascular Electrophysiology. 31(12). 3293–3301. 7 indexed citations
18.
Gulati, Rajiv, Atta Behfar, Jagat Narula, et al.. (2020). Acute Myocardial Infarction in Young Individuals. Mayo Clinic Proceedings. 95(1). 136–156. 215 indexed citations breakdown →
19.
Al‐Hijji, Mohammed, Ryan J. Lennon, Rajiv Gulati, et al.. (2017). Abstract 14914: Safety and Risk of Diagnostic Cardiac Catheterization. Circulation. 1 indexed citations
20.
Bartunek, Jozef, Atta Behfar, Dariouch Dolatabadi, et al.. (2012). Abstract 18117: Cardiopoietic Stem Cell Therapy In Heart Failure: The Multicenter Randomized C-cure Trial. Circulation. 126. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026